IFLR1000
The US private equity investor SK Capital LP has acquired the Swixx BioPharma Group. The Swixx BioPharma Group is a leading global full-service partner in the distribution of biopharmaceutical products, particularly in Central and Eastern Europe and Latin America.
Bär & Karrer - Switzerland,
December 15 2025